Gina L. Mazza

Also affiliated with Mayo Clinic Hospital

Economics, Econometrics and FinanceMedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 19 papers. Top paper: “An Exploratory Analysis of the “Was It Worth It?” Questionnaire as a Novel Metric to Capture Patient Perceptions of Cancer Treatment”.

An Exploratory Analysis of the “Was It Worth It?” Questionnaire as a Novel Metric to Capture Patient Perceptions of Cancer Treatment

Value in Health(2022)10.1016/j.jval.2021.11.1368

N/A

0.870DataRank · unranked

18 citations

Ethan Basch, Carolyn Mead‐Harvey, Antonia V. Bennett, Gina L. Mazza, Gisela Schwab +4 more

Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39)

Quality of Life Research(2024)10.1007/s11136-024-03675-3

N/A

0.434DataRank · unranked

17 citations

Amylou C. Dueck, Brenda Ginos, Jennifer Jansen, Allison M. Deal, Philip Carr +9 more

Methods for implementing and reporting the Patient‐Reported Outcomes version of the Common Terminology Criteria for Adverse Events to measure patient‐reported adverse events in cancer clinical trials

Cancer(2025)10.1002/cncr.35951

N/A

0.360DataRank · unranked

10 citations

Gita Thanarajasingam, Lauren Rogak, Gina L. Mazza, Blake T. Langlais, Brie N. Noble +8 more

Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden

Cancers(2025)10.3390/cancers17213459

N/A

0.269DataRank · unranked

5 citations

Sandra A. Mitchell, Ethan Basch, Allison M. Deal, Blake Langlais, Gita Thanarajasingam +8 more

Graphical representations of patient tolerability data: Recommendations from the National Cancer Institute (NCI) Cancer Moonshot Standardization Working Group.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e18612

N/A

0.241DataRank · unranked

4 citations

Gina L. Mazza, Blake Langlais, Bellinda L. King‐Kallimanis, Lauren J. Rogak, Patient Tolerability Consortia Standardization Working Group +1 more

Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE ® ) in a diverse cancer sample

Clinical Trials(2024)10.1177/17407745241286065

N/A

0.208DataRank · unranked

3 citations

Ethan Basch, Lauren Rogak, Blake Langlais, Gita Thanarajasingam, Brenda Ginos +10 more

When to adjust for multiplicity in cancer clinical trials

JNCI Monographs(2025)10.1093/jncimonographs/lgae051

N/A

0.165DataRank · unranked

2 citations

Gina L. Mazza, Mohamed I. Elsaid, Fenghai Duan, Emily V. Dressler, Anna C. Snavely +3 more

Longitudinal graphics of patient-reported physical function in patients treated for hematologic malignancies

BMC Medical Research Methodology(2025)10.1186/s12874-025-02617-y

N/A

0.165DataRank · unranked

2 citations

Vishal Bhatnagar, Brie N. Noble, Tingyu Chen, Mallorie H. Fiero, Ron Hoffman +11 more

Design and analysis considerations for investigating patient subgroups of interest within cancer clinical trials

JNCI Monographs(2025)10.1093/jncimonographs/lgae045

N/A

0.104DataRank · unranked

1 citations

Eva Culakova, Danielle Enserro, James J. Dignam, Joseph M. Unger, Gina L. Mazza

Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies

American Journal of Neuroradiology(2020)10.3174/ajnr.a6486

N/A

0DataRank · unranked

34 citations

Jennifer Eschbacher, Ashlyn C Gonzales, Kyle Singleton, Gustavo De León, Kris A. Smith +16 more

Impact of gender representativeness in online symptom survey and clinical trial participation among patients with myeloproliferative neoplasms

Leukemia & lymphoma/Leukemia and lymphoma(2024)10.1080/10428194.2024.2356058

N/A

0DataRank · unranked

3 citations

Amylou C. Dueck, Heidi Kosiorek, Carolyn Mead‐Harvey, Eric A. Meek, Lauren J. Rogak +9 more

Use of patient-reported outcomes version of the common terminology criteria for adverse events in oncology clinical trials

Contemporary Clinical Trials Communications(2025)10.1016/j.conctc.2025.101547

N/A

0DataRank · unranked

8 citations

Jamie K. Forschmiedt, Ethan Basch, Gina L. Mazza, Minji K. Lee, Eric A. Meek +8 more

Goal attainment in PMM2-CDG: A new approach measuring meaningful clinical outcomes

Molecular Genetics and Metabolism(2025)10.1016/j.ymgme.2025.109087

N/A

0DataRank · unranked

2 citations

Gina L. Mazza, Andrew C. Edmondson, Fernando Scaglia, Seishu Horikoshi, Bryce Kuschel +11 more

Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment With Standard-of-Care

Frontiers in Oncology(2020)10.3389/fonc.2020.580750

N/A

0DataRank · unranked

18 citations

Paula Whitmire, Cassandra Rickertsen, Gina L. Mazza, Peter Canoll, Sandra K. Johnston +4 more

Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma

Scientific Reports(2021)10.1038/s41598-021-83141-z

N/A

0DataRank · unranked

30 citations

Lujia Wang, Andrea Hawkins‐Daarud, Jennifer Eschbacher, Kyle Singleton, Pamela Jackson +20 more

Momentary Self-regulation: Scale Development and Preliminary Validation

JMIR Mental Health(2022)10.2196/35273

N/A

0DataRank · unranked

5 citations

Sunny Jung Kim, Stephen A. Metcalf, M. A. Sweeney, Jialing Wu, Haiyi Xie +5 more

Impact of imbalanced gender participation in online myeloproliferative neoplasm symptom surveys.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e19078

N/A

0DataRank · unranked

5 citations

Gina L. Mazza, Robyn M. Scherber, Holly L. Geyer, Krisstina Gowin, Jeanne Palmer +6 more

Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures

Nature Communications(2023)10.1038/s41467-023-41559-1

N/A

0DataRank · unranked

53 citations

Fulvio D’Angelo, Taylor M. Weiskittel, Francesca Pia Caruso, Shannon P. Fortin Ensign, Mylan Blomquist +55 more

Alliance A032002 (ART): Phase II randomized trial of atezolizumab versus atezolizumab and radiation therapy for platinum-ineligible/refractory metastatic urothelial cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.tps589

N/A

0DataRank · unranked

1 citations

Karla V. Ballman, Scott T. Tagawa, Alan Tan, Bishoy M. Faltas, Arshin Sheybani +11 more